Michael Gold to Medicare
This is a "connection" page, showing publications Michael Gold has written about Medicare.
Connection Strength
0.424
-
The cost of non-response to cardiac resynchronization therapy: characterizing heart failure events following cardiac resynchronization therapy. Europace. 2021 10 09; 23(10):1586-1595.
Score: 0.157
-
The problematic lag between FDA approval of medical devices and CMS coverage. J Cardiovasc Electrophysiol. 2021 07; 32(7):1801-1802.
Score: 0.153
-
Economic Value and Cost-Effectiveness of?Cardiac Resynchronization Therapy Among Patients With Mild Heart Failure: Projections From the REVERSE Long-Term Follow-Up. JACC Heart Fail. 2017 03; 5(3):204-212.
Score: 0.113